These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endoscopic factors? Chiu PW; Joeng HK; Choi CL; Kwong KH; Ng EK; Lam SH Endoscopy; 2006 Jul; 38(7):726-9. PubMed ID: 16810597 [TBL] [Abstract][Full Text] [Related]
43. Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: an analysis of two prospective clinical trials. Gralnek IM; Jensen DM; Gornbein J; Kovacs TO; Jutabha R; Freeman ML; King J; Jensen ME; Cheng S; Machicado GA; Smith JA; Randall GM; Sue M Am J Gastroenterol; 1998 Nov; 93(11):2047-56. PubMed ID: 9820371 [TBL] [Abstract][Full Text] [Related]
44. The "Prometeo" study: online collection of clinical data and outcome of Italian patients with acute nonvariceal upper gastrointestinal bleeding. Del Piano M; Bianco MA; Cipolletta L; Zambelli A; Chilovi F; Di Matteo G; Pagliarulo M; Ballarè M; Rotondano G; J Clin Gastroenterol; 2013 Apr; 47(4):e33-7. PubMed ID: 22914349 [TBL] [Abstract][Full Text] [Related]
45. [Peptic ulcer with a visible non-bleeding vascular wall--early elective surgery or endoscopic therapy?]. Sandbichler P; Pernthaler H; Ofner D; Königsrainer A; Schwab G; Aigner F Wien Klin Wochenschr; 1989 Nov; 101(21):736-8. PubMed ID: 2588595 [TBL] [Abstract][Full Text] [Related]
46. Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Chiu PW; Ng EK; Cheung FK; Chan FK; Leung WK; Wu JC; Wong VW; Yung MY; Tsoi K; Lau JY; Sung JJ; Chung SS Clin Gastroenterol Hepatol; 2009 Mar; 7(3):311-6; quiz 253. PubMed ID: 18955161 [TBL] [Abstract][Full Text] [Related]
47. Factors identifying the probability of further haemorrhage after acute upper gastrointestinal haemorrhage. MacLeod IA; Mills PR Br J Surg; 1982 May; 69(5):256-8. PubMed ID: 6978753 [TBL] [Abstract][Full Text] [Related]
48. The effect of introducing endoscopic therapy on surgery and mortality rates for peptic ulcer hemorrhage. A single center analysis of 1,125 cases. Fullarton GM; Birnie GG; MacDonald A; Murray WR Endoscopy; 1990 May; 22(3):110-3. PubMed ID: 2357933 [TBL] [Abstract][Full Text] [Related]
49. Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease. Kuo MT; Yang SC; Lu LS; Hsu CN; Kuo YH; Kuo CH; Liang CM; Kuo CM; Wu CK; Tai WC; Chuah SK BMC Gastroenterol; 2015 May; 15():61. PubMed ID: 26268474 [TBL] [Abstract][Full Text] [Related]
52. Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study. Yüksel I; Ataseven H; Köklü S; Ertuğrul I; Başar O; Odemiş B; Ibiş M; Saşmaz N; Sahin B Digestion; 2008; 78(1):39-43. PubMed ID: 18824852 [TBL] [Abstract][Full Text] [Related]
53. The evolution of stigmata of hemorrhage in bleeding peptic ulcers: a sequential endoscopic study. Lau JY; Chung SC; Leung JW; Lo KK; Yung MY; Li AK Endoscopy; 1998 Aug; 30(6):513-8. PubMed ID: 9746158 [TBL] [Abstract][Full Text] [Related]
54. [Risk factors of persistent or recurrent bleeding and mortality in peptic ulcer hemorrhage]. Mueller X; Rothenbühler JM; Amery A; Harder F Helv Chir Acta; 1994 Apr; 60(4):661-4. PubMed ID: 8034551 [TBL] [Abstract][Full Text] [Related]